Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

Charles River Laboratories International, Inc.

NYSE

Market Cap.

11.19B

Avg. Volume

522.58K

AI Analyst

AI

Streamlined AI Analyst

Hi I’m your personal financial assistant, click on one of the options below and I’ll help you analyze Charles River Laboratories International, Inc.!

Still processing it, give me a bit more time...

Charles River Laboratories International, Inc. News

Charles River Laboratories International, Inc. Score

Overall Score

Growth

Value

Quality

Moment.

Momentum

Stability

Website screenshot
HealthcareMedical - Diagnostics & Research
criver.com

About Charles River Laboratories International, Inc.

Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodent research model strains and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening non-clinical drug candidates, including research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for the identification and validation of novel targets, chemical compounds, and antibodies through delivery of non-clinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products. This segment also offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies; and avian vaccine services that provide specific-pathogen-free (SPF) fertile chicken eggs, SPF chickens, and diagnostic products used to manufacture vaccines. The company also provides contract vivarium operation services to biopharmaceutical clients. Charles River Laboratories International, Inc. was founded in 1947 and is headquartered in Wilmington, Massachusetts.

Charles River Laboratories International, Inc. Earnings & Revenue

Charles River Laboratories International, Inc. Financials

Table Compare

Compare CRL metrics with:

   

Earnings & Growth

CRL

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

CRL

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

CRL

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

CRL

None

Debt Ratio

--

--

Quick Ratio

--

--

 

Charles River Laboratories International, Inc. Income

Charles River Laboratories International, Inc. Balance Sheet

Charles River Laboratories International, Inc. Cash Flow

Charles River Laboratories International, Inc. Financials Over Time

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsBuy
Return on EquityBuy
Return on AssetsBuy
Debt/Equity RatioStrong Buy
Price/Earnings RatioStrong Buy
Price/Book RatioBuy

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Historical Market Cap

Shares Outstanding

Charles River Laboratories International, Inc. Executives

NameRole
Mr. James C. Foster J.D.Chief Executive Officer, President & Chairman
Ms. Flavia H. PeaseCorporate Executive Vice President & Chief Financial Officer
Ms. Birgit GirshickCorporate Executive Vice President & Chief Operating Officer
Mr. William D. BarboCorporate Executive Vice President of Community Relations
Mr. Joseph W. LaPlumeCorporate Executive Vice President of Corporate Development & Strategy
NameRoleGenderDate of BirthPay
Mr. James C. Foster J.D.Chief Executive Officer, President & ChairmanMale19512.66M
Ms. Flavia H. PeaseCorporate Executive Vice President & Chief Financial OfficerFemale19731.66M
Ms. Birgit GirshickCorporate Executive Vice President & Chief Operating OfficerFemale19701.28M
Mr. William D. BarboCorporate Executive Vice President of Community RelationsMale19611M
Mr. Joseph W. LaPlumeCorporate Executive Vice President of Corporate Development & StrategyMale1974928.36K

Charles River Laboratories International, Inc. Insider Trades

Date15 May
NameMASSARO GEORGE
RoleDirector
TransactionDisposed
TypeS-Sale
Shares123
Date15 May
NameMASSARO GEORGE
RoleDirector
TransactionDisposed
TypeS-Sale
Shares113
Date15 May
NameMASSARO GEORGE
RoleDirector
TransactionDisposed
TypeS-Sale
Shares96
Date13 May
NameWILSON VIRGINIA M
RoleDirector
TransactionAcquired
TypeA-Award
Shares559
Date13 May
NameWILSON VIRGINIA M
RoleDirector
TransactionAcquired
TypeA-Award
Shares1311
DateNameRoleTransactionTypeShares
15 MayMASSARO GEORGEDirectorDisposedS-Sale123
15 MayMASSARO GEORGEDirectorDisposedS-Sale113
15 MayMASSARO GEORGEDirectorDisposedS-Sale96
13 MayWILSON VIRGINIA MDirectorAcquiredA-Award559
13 MayWILSON VIRGINIA MDirectorAcquiredA-Award1311

Discover More

Streamlined Academy

Charles River Laboratories International, Inc.

NYSE

Market Cap.

11.19B

Avg. Volume

522.58K

Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

Charles River Laboratories International, Inc. News

Charles River Laboratories International, Inc. Score

Overall Score

Growth

Value

Quality

Moment.

Momentum

Stability

Charles River Laboratories International, Inc. Earnings & Revenue

Charles River Laboratories International, Inc. Income

Charles River Laboratories International, Inc. Balance Sheet

Charles River Laboratories International, Inc. Cash Flow

Charles River Laboratories International, Inc. Financials Over Time

Charles River Laboratories International, Inc. Executives

NameRole
Mr. James C. Foster J.D.Chief Executive Officer, President & Chairman
Ms. Flavia H. PeaseCorporate Executive Vice President & Chief Financial Officer
Ms. Birgit GirshickCorporate Executive Vice President & Chief Operating Officer
Mr. William D. BarboCorporate Executive Vice President of Community Relations
Mr. Joseph W. LaPlumeCorporate Executive Vice President of Corporate Development & Strategy
NameRoleGenderDate of BirthPay
Mr. James C. Foster J.D.Chief Executive Officer, President & ChairmanMale19512.66M
Ms. Flavia H. PeaseCorporate Executive Vice President & Chief Financial OfficerFemale19731.66M
Ms. Birgit GirshickCorporate Executive Vice President & Chief Operating OfficerFemale19701.28M
Mr. William D. BarboCorporate Executive Vice President of Community RelationsMale19611M
Mr. Joseph W. LaPlumeCorporate Executive Vice President of Corporate Development & StrategyMale1974928.36K

Charles River Laboratories International, Inc. Insider Trades

Date15 May
NameMASSARO GEORGE
RoleDirector
TransactionDisposed
TypeS-Sale
Shares123
Date15 May
NameMASSARO GEORGE
RoleDirector
TransactionDisposed
TypeS-Sale
Shares113
Date15 May
NameMASSARO GEORGE
RoleDirector
TransactionDisposed
TypeS-Sale
Shares96
Date13 May
NameWILSON VIRGINIA M
RoleDirector
TransactionAcquired
TypeA-Award
Shares559
Date13 May
NameWILSON VIRGINIA M
RoleDirector
TransactionAcquired
TypeA-Award
Shares1311
DateNameRoleTransactionTypeShares
15 MayMASSARO GEORGEDirectorDisposedS-Sale123
15 MayMASSARO GEORGEDirectorDisposedS-Sale113
15 MayMASSARO GEORGEDirectorDisposedS-Sale96
13 MayWILSON VIRGINIA MDirectorAcquiredA-Award559
13 MayWILSON VIRGINIA MDirectorAcquiredA-Award1311

Streamlined Academy

Website screenshot
HealthcareMedical - Diagnostics & Research
criver.com

About Charles River Laboratories International, Inc.

Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodent research model strains and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening non-clinical drug candidates, including research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for the identification and validation of novel targets, chemical compounds, and antibodies through delivery of non-clinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products. This segment also offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies; and avian vaccine services that provide specific-pathogen-free (SPF) fertile chicken eggs, SPF chickens, and diagnostic products used to manufacture vaccines. The company also provides contract vivarium operation services to biopharmaceutical clients. Charles River Laboratories International, Inc. was founded in 1947 and is headquartered in Wilmington, Massachusetts.

AI Analyst

AI

Streamlined AI Analyst

Hi I’m your personal financial assistant, click on one of the options below and I’ll help you analyze Charles River Laboratories International, Inc.!

Still processing it, give me a bit more time...

Charles River Laboratories International, Inc. Financials

Table Compare

Compare CRL metrics with:

   

Earnings & Growth

CRL

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

CRL

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

CRL

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

CRL

None

Debt Ratio

--

--

Quick Ratio

--

--

 

Charles River Laboratories International, Inc. Valuation

Project future cash flows and get the intrinsic value per share.

Start valuation modeling

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsBuy
Return on EquityBuy
Return on AssetsBuy
Debt/Equity RatioStrong Buy
Price/Earnings RatioStrong Buy
Price/Book RatioBuy

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Historical Market Cap

Shares Outstanding

Discover More